visualizations
Litherland, Sally A, PhD, MS, MS
Overview
Publications
Most Recent Publications
-
2022Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function. JOURNAL OF MEDICINAL CHEMISTRY.Full Text via DOI: 10.1021/acs.jmedchem.2c01350 PMID: 36382923
-
2021Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist Pharmacology at the hMC4R. ACS CHEMICAL NEUROSCIENCE. 12:542-556.Full Text via DOI: 10.1021/acschemneuro.0c00755 PMID: 33470098
-
2020Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells. CELL COMMUNICATION AND SIGNALING. 18.Full Text via DOI: 10.1186/s12964-020-00594-x PMID: 32552827
-
2019K-RAS Mutant Gene Found in Pancreatic Juice Activated Chromatin From Peri-ampullary Adenocarcinomas. EPIGENETICS INSIGHTS. 12.Full Text via DOI: 10.1177/2516865719828348 PMID: 30815628
-
2018Targeting lysophospholipid metabolism inhibits pancreatic cancer cell proliferation under nutrient-limiting conditions. CANCER RESEARCH.Full Text via DOI: 10.1158/1538-7445.AM2018-2916
-
2018Portal Vein Circulating Tumor Cells (CTC) Conform Multi-Cellular Type Clusters in Patients with Peri-Ampullary Carcinomas. ANNALS OF SURGICAL ONCOLOGY. S122-S122.
-
2018Pancreatic and bile duct cancer circulating tumor cells (CTC) form immune-resistant multi-cell type clusters in the portal venous circulation. CANCER BIOLOGY & THERAPY. 19:887-897.Full Text via DOI: 10.1080/15384047.2018.1480292 PMID: 30067440
-
2017Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation. PANCREAS. 46:116-123.Full Text via DOI: 10.1097/MPA.0000000000000667 PMID: 27400259
-
2016Blatchford Score Is Superior to AIMS65 Score in Predicting the Need for Clinical Interventions in Elderly Patients with Nonvariceal Upper Gastrointestinal Bleed.. Advances in medicine. 6850754.Full Text via DOI: 10.1155/2016/6850754 PMID: 27648468
-
2015Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetesprone Bicongenic B6. NODC11bxC1tb Mice. GENETICS & EPIGENETICS. 7:5-17.Full Text via DOI: 10.4137/GEG.S29696 PMID: 26512207
-
2014Ethnicity Disparities of Breast Cancer within an Insured Population. BREAST JOURNAL. 331-332.Full Text via DOI: 10.1111/tbj.12271 PMID: 24750514
-
2013Ethnicity disparities of breast cancer in an insured population. CANCER RESEARCH.Full Text via DOI: 10.1158/0008-5472.SABCS13-P5-12-04
-
2013Persistent STAT5 Phosphorylation and Epigenetic Dysregulation of GM-CSF and PGS2/COX2 Expression in Type 1 Diabetic Human Monocytes. PLOS ONE. 8.Full Text via DOI: 10.1371/journal.pone.0076919 PMID: 24204704
-
2012Developing a nanoparticle test for prostate cancer scoring. JOURNAL OF TRANSLATIONAL MEDICINE. 10.Full Text via DOI: 10.1186/1479-5876-10-44 PMID: 22404986
-
2012In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. AMERICAN JOURNAL OF STEM CELLS. 1:114-127.PMID: 22833839
-
2010Pharmacological Characterization of 30 Human Melanocortin-4 Receptor Polymorphisms with the Endogenous Proopiomelanocortin-Derived Agonists, Synthetic Agonists, and the Endogenous Agouti-Related Protein Antagonist. BIOCHEMISTRY. 49:4583-4600.Full Text via DOI: 10.1021/bi100068u PMID: 20462274
-
2009Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse. FASEB JOURNAL. 23:642-655.Full Text via DOI: 10.1096/fj.08-109686 PMID: 18971258
-
2009Construction and Characterization of Melanocortin-2 and-4 Receptor Chimeras. PEPTIDES FOR YOUTH. 611:301-302.Full Text via DOI: 10.1007/978-0-387-73657-0_135 PMID: 19400202
-
2009Discovery of a Ligand that Compensates for Decreased Endogenous Agonist Potency of Melanocortin-4 Receptor Polymorphisms Identified in Obese Humans. PEPTIDES FOR YOUTH. 611:509-510.Full Text via DOI: 10.1007/978-0-387-73657-0_221 PMID: 19400288
-
2008GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells. JOURNAL OF AUTOIMMUNITY. 31:377-384.Full Text via DOI: 10.1016/j.jaut.2008.08.010 PMID: 18945591
-
2008Immunopathogenic Interaction of Environmental Triggers and Genetic Susceptibility in Diabetes Is Epigenetics the Missing Link?. DIABETES. 3184-3186.Full Text via DOI: 10.2337/db08-1275 PMID: 19033405
-
2008M-CSF and GM-CSF Regulation of STAT5 Activation and DNA Binding in Myeloid Cell Differentiation is Disrupted in Nonobese Diabetic Mice. CLINICAL & DEVELOPMENTAL IMMUNOLOGY.Full Text via DOI: 10.1155/2008/769795 PMID: 19165346
-
2007Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms. BIOCHEMISTRY. 46:8273-8287.Full Text via DOI: 10.1021/bi7007382 PMID: 17590021
-
2007Truncated pStat5B is associated with the Idd4 locus in NOD mice. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 356:655-661.Full Text via DOI: 10.1016/j.bbrc.2007.03.028 PMID: 17382905
-
2007Characterization of HKE2: an ancient antigen encoded in the major histocompatibility complex. TISSUE ANTIGENS. 69:181-188.Full Text via DOI: 10.1111/j.1399-0039.2006.00730.x PMID: 17257322
-
2006Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the Agouti-related protein (AGRP) antagonist. BIOCHEMISTRY. 45:7277-7288.Full Text via DOI: 10.1021/bi0600300 PMID: 16752916
-
2006Molecular mechanism of the constitutive activation of the L250Q human melanocortin-4 receptor polymorphism. CHEMICAL BIOLOGY & DRUG DESIGN. 67:215-229.Full Text via DOI: 10.1111/j.1747-0285.2006.00362.x PMID: 16611215
-
2006Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent - Implications for the NOD STAT5B mutation in diabetes pathogenesis. IMMUNOLOGY OF DIABETES IV: PROGRESS IN OUR UNDERSTANDING. 1079:198-204.Full Text via DOI: 10.1196/annals.1375.031 PMID: 17130555
-
2005Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages. JOURNAL OF AUTOIMMUNITY. 24:297-310.Full Text via DOI: 10.1016/j.jaut.2005.02.001 PMID: 15927792
-
2004Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles. ANALYTICAL BIOCHEMISTRY. 334:135-144.Full Text via DOI: 10.1016/j.ab.2004.08.005 PMID: 15464962
-
2004In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. DIABETES. 53:1721-1732.PMID: 15220196
-
2004IL10 resistant PGS2 expression in at-risk/Type 1 diabetic human monocytes. JOURNAL OF AUTOIMMUNITY. 22:227-233.Full Text via DOI: 10.1016/j.jaut.2003.12.006 PMID: 15041043
-
2003CapG(-/-) mice have specific host defense defects that render them more susceptible than CapG(+/+) mice to Listeria monocytogenes infection but not to Salmonella enterica serovar typhimurium infection. INFECTION AND IMMUNITY. 71:6582-6590.Full Text via DOI: 10.1128/IAI.71.11.6582-6590.2003 PMID: 14573680
-
2003Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.. PEDIATRIC DIABETES. 10-8.PMID: 14655518
-
2003Abnormal peripheral blood dendritic cell populations in type 1 diabetes. IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN. 1005:222-225.Full Text via DOI: 10.1196/annals.1288.031 PMID: 14679064
-
1999Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus. JOURNAL OF CLINICAL INVESTIGATION. 104:515-523.PMID: 10449443
Background
Full Name
- Sally A Litherland, PhD